Jane Street Group, LLC Bio Xcel Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 49,317 shares of BTAI stock, worth $25,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,317

Previous 125,046 60.56%

Holding current value

$25,151

Previous $160,000 81.25%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $1.34 $40,136 - $101,476	-75,729 Reduced 60.56%	49,317 $30,000
Q2 2024 Aug 14, 2024	BUY	$1.14 - $2.97 $142,552 - $371,386	125,046 New	125,046 $160,000
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $256,666 - $609,582	-110,632 Reduced 78.09%	31,043 $91,000
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $101,357 - $482,366	40,706 Added 40.32%	141,675 $358,000
Q2 2023 Aug 14, 2023	BUY	$6.39 - $28.58 $576,742 - $2.58 Million	90,257 Added 842.58%	100,969 $672,000
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $189,602 - $356,066	10,712 New	10,712 $199,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $141,732 - $226,594	12,666 New	12,666 $150,000
Q2 2022 Aug 16, 2022	SELL	$9.03 - $21.55 $704,376 - $1.68 Million	-78,004 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$15.0 - $22.83 $818,430 - $1.25 Million	54,562 Added 232.75%	78,004 $1.63 Million
Q4 2021 Feb 15, 2022	BUY	$20.12 - $35.09 $267,354 - $466,275	13,288 Added 130.86%	23,442 $476,000
Q3 2021 Nov 16, 2021	SELL	$23.84 - $32.03 $141,704 - $190,386	-5,944 Reduced 36.92%	10,154 $308,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $358,861 - $479,511	-12,349 Reduced 43.41%	16,098 $468,000
Q1 2021 May 18, 2021	BUY	$39.04 - $64.6 $29,748 - $49,225	762 Added 2.75%	28,447 $1.23 Million
Q4 2020 Feb 17, 2021	SELL	$42.46 - $56.58 $1.91 Million - $2.55 Million	-45,036 Reduced 61.93%	27,685 $1.28 Million
Q3 2020 Nov 17, 2020	BUY	$37.44 - $64.63 $2.52 Million - $4.34 Million	67,188 Added 1214.31%	72,721 $3.15 Million
Q2 2020 Aug 17, 2020	SELL	$17.62 - $58.71 $91,007 - $303,237	-5,165 Reduced 48.28%	5,533 $294,000
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $131,157 - $440,115	10,698 New	10,698 $239,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Bio Xcel Therapeutics, Inc. Transaction History